Brokerages expect Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) (TSE:AUP) to report ($0.22) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Four analysts have provided estimates for Aurinia Pharmaceuticals’ earnings. The lowest EPS estimate is ($0.25) and the highest is ($0.20). Aurinia Pharmaceuticals posted earnings of ($0.21) per share […]

Brokerages expect Enanta Pharmaceuticals Inc (NASDAQ:ENTA) to report $40.12 million in sales for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for Enanta Pharmaceuticals’ earnings. The highest sales estimate is $87.82 million and the lowest is $21.32 million. Enanta Pharmaceuticals reported sales of $51.31 million […]

Analysts expect that Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) will announce $38.62 million in sales for the current fiscal quarter, according to Zacks. Six analysts have provided estimates for Arrowhead Pharmaceuticals’ earnings, with estimates ranging from $10.00 million to $104.80 million. Arrowhead Pharmaceuticals posted sales of $43.29 million during the same quarter […]

BHR specializes in innovative diagnostic solutions for point of care Collaboration focusses on SphingoTec’s proprietary assays for bio-ADM(R), penKid(R) and DPP3 Investigator-initiated study in COVID-19 at Guy’s & St Thomas’ Hospital and King’s College Hospital NHS Trust WARWIICKSHIRE, UK and HENNIGDORF, GERMANY / ACCESSWIRE / September 29, 2020 / BHR […]

EDISON, NJ / ACCESSWIRE / September 29, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis (“NASH”), today announced that Dr. Robert Foster, Hepion’s CEO, will present virtually at the H.C. Wainwright 4th […]